成長し,出血する紫のモルです.

Same author

Dietary patterns, metabolic pathways and metainflammation in hidradenitis suppurativa: a systematic review.

Frontiers in immunology·2026

Same author

Criteria for Hidradenitis Suppurativa Competence Centers.

Dermatology and therapy·2026

Same author

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

JAMA dermatology·2026

Same author

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment.

American journal of clinical dermatology·2026

Same author

Burden of hidradenitis suppurativa in Germany: a retrospective claims data analysis and comparison with non-HS patients.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Same author

The role of surgery in hidradenitis suppurativa: Expert-based holistic approaches.

Clinical and experimental dermatology·2026

Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026

Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026

Same journal

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Lancet (London, England)·2026

関連する実験動画

成長し,出血する紫のモルです.

関連する概念動画

Dietary patterns, metabolic pathways and metainflammation in hidradenitis suppurativa: a systematic review.

Criteria for Hidradenitis Suppurativa Competence Centers.

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment.

Burden of hidradenitis suppurativa in Germany: a retrospective claims data analysis and comparison with non-HS patients.

The role of surgery in hidradenitis suppurativa: Expert-based holistic approaches.

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

関連する実験動画

成長し,出血する紫のモルです.

関連する概念動画

関連記事

Dietary patterns, metabolic pathways and metainflammation in hidradenitis suppurativa: a systematic review.

Criteria for Hidradenitis Suppurativa Competence Centers.

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment.

Burden of hidradenitis suppurativa in Germany: a retrospective claims data analysis and comparison with non-HS patients.

The role of surgery in hidradenitis suppurativa: Expert-based holistic approaches.

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.